Topical Retinoids in Acne Vulgaris and Acne Scars—From Monotherapy to Combining Regimens
Pharmaceuticals · 15.04.2026 · 19 (4) · 620
DOI: 10.3390/ph19040620 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.04.2026. Verfasst von Aleksandra Tobiasz und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Centre of General Dermatology and Oncodermatology, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Topical retinoids are the cornerstone of the treatment of multiple dermatological conditions. Long established in acne therapy, they exert effects on keratinization, inflammation, fibroblast activity, and collagen remodeling, suggesting a potential role in both the prevention and treatment of acne scars. This narrative review summarizes current evidence on the use of topical retinoids in acne vulgaris and acne scarring, focusing on different retinoid molecules, formulation technologies, and combination strategies. A review of published clinical and experimental studies evaluating tretinoin, adapalene, tazarotene, and trifarotene was performed, including their use as monotherapy and in combination with other topical agents or procedural interventions. The available data indicate that topical retinoids have a well-established position in acne treatment, can improve the appearance of atrophic acne scars, reduce the progression of scarring, and support skin remodeling. Advances in formulation technologies have improved tolerability, while combination approaches with agents such as benzoyl peroxide, antibiotics or procedural techniques have shown additive or synergistic effects, particularly in more severe cases. Nevertheless, much of the evidence regarding novel formulations is derived from small or heterogeneous study populations. In conclusion, topical retinoids represent a relevant therapeutic option in acne vulgaris and acne scarring, from monotherapy in mild cases to components of multimodal treatment protocols in more severe disease. Further large-scale, comparative studies are needed to better define the optimal clinical use of advanced drug delivery systems for topical retinoids.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Centre of General Dermatology and Oncodermatology, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland.
ORCID-Profile: Alina Jankowska-Konsur, Danuta Nowicka
Zitieren
APA
Tobiasz, A., Jankowska-Konsur, A., & Nowicka, D. (2026). Topical Retinoids in Acne Vulgaris and Acne Scars—From Monotherapy to Combining Regimens. Pharmaceuticals, 19(4), 620. https://doi.org/10.3390/ph19040620
Vancouver
Tobiasz A, Jankowska-Konsur A, Nowicka D. Topical Retinoids in Acne Vulgaris and Acne Scars—From Monotherapy to Combining Regimens. Pharmaceuticals. 2026;19(4):620. doi:10.3390/ph19040620
BibTeX
@article{Tobiasz2026,
author = {Tobiasz, Aleksandra and Jankowska-Konsur, Alina and Nowicka, Danuta},
title = {Topical Retinoids in Acne Vulgaris and Acne Scars—From Monotherapy to Combining Regimens},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {4},
pages = {620},
doi = {10.3390/ph19040620}
}
EUVIMED